LMF
FOLD

LMR Master Fund’s Amicus Therapeutics FOLD Stock Holding History

LMR Master Fund’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$81K Buy
+34,354
New +$75.4K 0.01% 330
2013
Q3 		– Sell
-18,543
Closed -$43K – 346
2013
Q2 		$43K Buy
+18,543
New +$57K ﹤0.01% 447

Other funds holding FOLD

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SEP
Sound Energy Partners Greenwich, Connecticut $49.5M AUM 35.64% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

LMR Master Fund's FOLD Position: Q4 2013 in Review

LMR Master Fund opened a new position in Amicus Therapeutics (FOLD) in Q4 2013: 34,354 shares worth $81K. The stake represents 0.01% of the portfolio and ranks #330 among its holdings. This is a return to the name: LMR Master Fund previously reported a position in FOLD as recently as Q2 2013.

LMR Master Fund first reported a position in FOLD in Q2 2013 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold FOLD as of Q4 2013.

  • LMR Master Fund held 34,354 shares of Amicus Therapeutics worth $81K as of Q4 2013.
  • Amicus Therapeutics was a new LMR Master Fund position in Q4 2013.
  • Amicus Therapeutics made up 0.01% of LMR Master Fund's portfolio in Q4 2013, its #330 holding.
  • LMR Master Fund first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.